Observations placeholder
Remodulin
Identifier
020142
Type of Spiritual Experience
None
Background
A description of the experience
Treprostinil (marketed under the trade names Remodulin for infusion and Tyvaso for inhalation) is a vasodilator
On Jan, 18, 2016: 3,942 people reported to have side effects when taking Remodulin. Among them, 1,990 people (50.48%) have Death.
Time on Remodulin when people have Death * :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 6.33% | 31.44% | 17.90% | 23.80% | 16.81% | 3.71% | 0.00% |
Gender of people who have Death when taking Remodulin * :
Female | Male | |
Death | 72.43% | 27.57% |
Age of people who have Death when taking Remodulin * :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 0.31% | 0.70% | 1.33% | 3.36% | 7.34% | 13.36% | 24.53% | 49.06% |